Open access
Jul 2026
CSF and plasma tau biomarkers in the Down syndrome–Alzheimer’s disease continuum
These findings highlight the complementary roles of CSF and plasma tau biomarkers in tracking disease progression: CSF biomarkers capture early pathological changes, whereas plasma biomarkers more effectively reflect disease progression within symptomatic stages.
J. Arranz, J. Lantero-Rodríguez, Luisa Sophie Braun-Wohlfahrt et al.
· EBioMedicine · 1 citation